Trial

NCT02245087

Eliminate Coronary Artery Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Condition
Coronary Artery Disease
Intervention
Atorvastatin
Why stopped
Lack of Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-01